Literature DB >> 17041942

RAI1 point mutations, CAG repeat variation, and SNP analysis in non-deletion Smith-Magenis syndrome.

Weimin Bi1, G Mustafa Saifi, Santhosh Girirajan, Xin Shi, Barbara Szomju, Helen Firth, R Ellen Magenis, Lorraine Potocki, Sarah H Elsea, James R Lupski.   

Abstract

Smith-Magenis syndrome (SMS) is a multiple congenital anomalies/mental retardation disorder characterized by distinct craniofacial features and neurobehavioral abnormalities usually associated with an interstitial deletion in 17p11.2. Heterozygous point mutations in the retinoic acid induced 1 gene (RAI1) have been reported in nine SMS patients without a deletion detectable by fluorescent in situ hybridization (FISH), implicating RAI1 haploinsufficiency as the cause of the major clinical features in SMS. All of the reported point mutations are unique and de novo. RAI1 contains a polymorphic CAG repeat and encodes a plant homeo domain (PHD) zinc finger-containing transcriptional regulator. We report a novel RAI1 frameshift mutation, c.3103delC, in a non-deletion patient with many SMS features. The deletion of a single cytosine occurs in a heptameric C-tract (CCCCCCC), the longest mononucleotide repeat in the RAI1 coding region. Interestingly, we had previously reported a frameshift mutation, c.3103insC, in the same mononucleotide repeat. Furthermore, all five single base frameshift mutations preferentially occurred in polyC but not polyG tracts. We also investigated the distribution of the polymorphic CAG repeats in both the normal population and the SMS patients as one potential molecular mechanism for variability of clinical expression. In this limited data set, there was no significant association between the length of CAG repeats and the SMS phenotype. However, we identified a 5-year-old girl with an apparent SMS phenotype who was a compound heterozygote for an RAI1 missense mutation inherited from her father and a polyglutamine repeat of 18 copies, representing the largest known CAG repeat in this gene, inherited from her mother. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041942     DOI: 10.1002/ajmg.a.31510

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  24 in total

1.  Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all null alleles are alike.

Authors:  Jiong Yan; Weimin Bi; James R Lupski
Journal:  Am J Hum Genet       Date:  2007-01-18       Impact factor: 11.025

2.  Abnormal circadian rhythm of melatonin in Smith-Magenis syndrome patients with RAI1 point mutations.

Authors:  Philip M Boone; Russel J Reiter; Daniel G Glaze; Dun-Xian Tan; James R Lupski; Lorraine Potocki
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

3.  Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2).

Authors:  Katherina Walz; Richard Paylor; Jiong Yan; Weimin Bi; James R Lupski
Journal:  J Clin Invest       Date:  2006-10-05       Impact factor: 14.808

4.  Important Roles of Ring Finger Protein 112 in Embryonic Vascular Development and Brain Functions.

Authors:  Jen-Hui Tsou; Ying-Chen Yang; Ping-Chieh Pao; Hui-Ching Lin; Nai-Kuei Huang; Shih-Ting Lin; Kuei-Sen Hsu; Che-Ming Yeh; Kuen-Haur Lee; Chu-Jen Kuo; De-Ming Yang; Jiann-Her Lin; Wen-Chang Chang; Yi-Chao Lee
Journal:  Mol Neurobiol       Date:  2016-03-07       Impact factor: 5.590

Review 5.  Frameshift mutation hotspot identified in Smith-Magenis syndrome: case report and review of literature.

Authors:  Hoa T Truong; Tracy Dudding; Christopher L Blanchard; Sarah H Elsea
Journal:  BMC Med Genet       Date:  2010-10-08       Impact factor: 2.103

6.  Functional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis Syndrome.

Authors:  Paulina Carmona-Mora; Carolina A Encina; Cesar P Canales; Lei Cao; Jessica Molina; Pamela Kairath; Juan I Young; Katherina Walz
Journal:  BMC Mol Biol       Date:  2010-08-25       Impact factor: 2.946

Review 7.  CNV and nervous system diseases--what's new?

Authors:  W Gu; J R Lupski
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

8.  Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1.

Authors:  Melanie Lacaria; Wenli Gu; James R Lupski
Journal:  Am J Med Genet A       Date:  2013-05-23       Impact factor: 2.802

9.  Review of disrupted sleep patterns in Smith-Magenis syndrome and normal melatonin secretion in a patient with an atypical interstitial 17p11.2 deletion.

Authors:  Eilis A Boudreau; Kyle P Johnson; Angela R Jackman; Jan Blancato; Marjan Huizing; Claude Bendavid; Marypat Jones; Settara C Chandrasekharappa; Alfred J Lewy; Ann C M Smith; R Ellen Magenis
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

10.  Mouse models of genomic syndromes as tools for understanding the basis of complex traits: an example with the smith-magenis and the potocki-lupski syndromes.

Authors:  P Carmona-Mora; J Molina; C A Encina; K Walz
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.